65 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
20
Discovery of 5-aryl-1,3-dihydro-2H-imidazo[4,5-b]pyridin-2-ones as positive allosteric modulators of metabotropic glutamate subtype-2 (mGlu2) receptors with efficacy in a preclinical model of psychosis.
Merck Research Laboratories
57
Discovery of 2-[5-(4-Fluorophenylcarbamoyl)pyridin-2-ylsulfanylmethyl]phenylboronic Acid (SX-517): Noncompetitive Boronic Acid Antagonist of CXCR1 and CXCR2.
Syntrix Biosystems
14
Identification, biological characterization and pharmacophoric analysis of a new potent and selective NK1 receptor antagonist clinical candidate.
Glaxosmithkline
14
Cinnamides as selective small-molecule inhibitors of a cellular model of breast cancer stem cells.
Broad Institute of Mit and Harvard
95
Designed multiple ligands. An emerging drug discovery paradigm.
Organon Laboratories
17
Structure-activity relationships of phomactin derivatives as platelet activating factor antagonists.
Sankyo
22
Synthesis of alkyl chain-modified ether lipids and evaluation of their in vitro cytotoxicity.
Laboratorios Menarini
43
Novel antagonists of platelet-activating factor. 2. Synthesis and structure-activity relationships of potent and long-acting heterofused [1,5]benzodiazepine and [1,4]diazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Pfizer
22
Novel antagonists of platelet-activating factor. 1. Synthesis and structure-activity relationships of benzodiazepine and benzazepine derivatives of 2-methyl-1-phenylimidazo[4,5-c]pyridine.
Pfizer
93
3-(2-(3-Pyridinyl)thiazolidin-4-oyl)indoles, a novel series of platelet activating factor antagonists.
Abbott Laboratories
36
Design and modeling of new platelet-activating factor antagonists. 1. Synthesis and biological activity of 1,4-bis(3',4',5'-trimethoxybenzoyl)-2-[[(substituted carbonyl and carbamoyl)oxy]methyl]piperazines.
Paris Diderot University
103
Analogues of platelet activating factor. 6. Mono- and bis-aryl phosphate antagonists of platelet activating factor.
American Cyanamid
88
(Pyridylcyanomethyl)piperazines as orally active PAF antagonists.
J. Uriach & C£A.S.A.
10
Development, synthesis, and biological evaluation of (-)-trans-(2S,5S)-2-[3-[(2-oxopropyl)sulfonyl]-4-n-propoxy-5-(3- hydroxypropoxy)-phenyl]-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran, a potent orally active platelet-activating factor (PAF) antagonist and its water-soluble prodrug phosphate ester.
Merck Research Laboratories
37
1,4-Dihydropyridines as antagonists of platelet activating factor. 1. Synthesis and structure-activity relationships of 2-(4-heterocyclyl)phenyl derivatives.
Pfizer
27
Platelet activating factor antagonists: synthesis and structure-activity studies of novel PAF analogues modified in the phosphorylcholine moiety.
Takeda Chemical Industries
4
A 3D-QSAR study on ginkgolides and their analogues with comparative molecular field analysis.
Chinese Academy of Sciences
18
Cyclic ether acetal platelet activating factor (PAF) receptor antagonists II: imidazo[4,5-c]pyridyl derivatives
TBA
28
Cyclic ether acetal platelet activating factor (PAF) receptor antagonists I: 3-pyridyl derivatives
TBA
3
Synthesis and biological activity of the platelet-activating factor antagonist ()-trans-2-(3-methoxy-4-phenylsulfonylethoxy-5-n-propylsulfonylphenyl)-5-(3,4,5-trimethoxyphenyl)tetrahydrofuran (L-671,284) and its analogs
TBA
4
Synthesis and biological activity of MK 287 (L-680,573): a potent, specific and orally active paf receptor antagonist
TBA
5
The discovery of CP-96,021 and CP-96,486, balanced, combined, potent and orally active leukotriene D4 (LTD4)/platelet activating factor (PAF) receptor antagonists.
TBA
6
Cyclopentathiophene Carboxamide Derivatives as PAFR Antagonists for Treating Ocular Diseases, Allergies, and Inflammation-Related Disorders.
Smith, Gambrell & Russell
1
Discovery of a novel, orally active, small molecule gonadotropin-releasing hormone (GnRH) receptor antagonist.
Pfizer
15
Chemistry, biosynthesis and biological activity of terpenoids and meroterpenoids in bacteria and fungi isolated from different marine habitats.
Iranian Fisheries Science Research Institute
15
Preparation of 7-substituted ginkgolide derivatives: potent platelet activating factor (PAF) receptor antagonists.
Columbia University
13
Ginkgolide derivatives for photolabeling studies: preparation and pharmacological evaluation.
Columbia University
20
In vitro platelet-activating factor receptor binding inhibitory activity of pinusolide derivatives: a structure-activity study.
Seoul National University
17
(+/-)-trans-2-[3-methoxy-4-(4-chlorophenylthioethoxy)-5-(N-methyl-N- hydroxyureidyl)methylphenyl]-5-(3,4, 5-trimethoxyphenyl)tetrahydrofuran (CMI-392), a potent dual 5-lipoxygenase inhibitor and platelet-activating factor receptor antagonist.
University of Virginia
90
Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists.
Abbott Laboratories
38
Analogues of platelet activating factor. 8. Antagonists of PAF containing an aromatic ring linked to a pyridinium ring.
American Cyanamid
76
Synthesis and structure-activity relationships of 1-acyl-4-((2-methyl-3-pyridyl)cyanomethyl)piperazines as PAF antagonists.
J. Uriach & CíA.
11
Structural modification of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinoline platelet activating factor receptor antagonists.
Sandoz Research Institute
34
Antitumor activity of 5-aryl-2,3-dihydroimidazo[2,1-a]isoquinolines.
Sandoz Research Institute
10
Development of a novel series of trialkoxyaryl derivatives as specific and competitive antagonists of platelet activating factor.
Wellcome Research Laboratories
34
Pyrido[2,1-b]quinazolinecarboxamide derivatives as platelet activating factor antagonists.
Hoffmann-La Roche
10
Conformation and activity of tetrahydrofuran lignans and analogues as specific platelet activating factor antagonists.
TBA
57
Pentadienyl carboxamide derivatives as antagonists of platelet-activating factor.
Roche Research Center
27
Biphenylcarboxamide derivatives as antagonists of platelet-activating factor.
Roche Research Center
13
Propenyl carboxamide derivatives as antagonists of platelet activating factor.
Hoffmann-La Roche
35
Thienotriazolodiazepines as platelet-activating factor antagonists. Steric limitations for the substituent in position 2.
Roche Research Center
78
Triazolobenzo- and triazolothienodiazepines as potent antagonists of platelet activating factor.
Roche Research Center
26
Dual antagonists of platelet activating factor and histamine. Identification of structural requirements for dual activity of N-Acyl-4-(5,6-dihydro-11H-benzo [5,6]cyclohepta-[1,2-b]pyridin-11-ylidene)piperidines.
Schering-Plough
19
4-substituted 2-alkoxytetrahydrofurans as potent and long-lasting PAF antagonists.
J. Uriach & CíA.
28
Synthesis and structure-activity relationships of a series of novel benzopyran-containing platelet activating factor antagonists.
Abbott Laboratories
3
Phenyl c-glucoside derivative containing deoxyglucose structure, preparation method and use thereof
Tianjin Institute of Pharmaceutical Research